In particular, NfL levels have been shown to reflect active brain disease, dynamically respond to therapeutic interventions, and offer prognostic information in a number of neuropsychiatric disorders, such as multiple sclerosis, neurodegenerative disorders, traumatic brain injuries, and depression [14, 19, 20]. This evidence concerns the gene NEFL and major depressive disorder.